Pediatric patients with HB in China have had similar OS and EFS rates in recent years compared to developed countries.
Wuhan Protocol is the first national guideline developed by Chinese Children's Cancer Group.
The protocol was proved to be feasible and effective in China.
Standardization of surgical resection and risk-based chemotherapy should be further optimized for pediatric HB patients.